![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
I Angel, R Niddam and SZ Langer
Department of Biology, Synthelabo Recherche (Laboratoires d'Etudes et de Recherches Synthelabo, Paris, France.
Alpha-2 adrenoceptor stimulation induces in the mouse a hyperglycemic response which is accompanied by a concomitant inhibition of insulin secretion. To test the possibility that one of the postulated subtypes of alpha-2 adrenoceptors is preferentially implicated in this response, we compared the interaction of several drugs with known selectivity toward alpha-2A or alpha-2B adrenoceptor subtypes in our model. The alpha-2A preferential agonist oxymetazoline induced in the mouse a hyperglycemic response similar to that of the nonselective alpha-2 adrenoceptor agonist UK 14.304. This hyperglycemic response to oxymetazoline was accompanied by a concomitant inhibition of insulin release. Both the effect on glycemic level and the inhibition of insulin release by oxymetazoline were antagonized by the alpha-2 adrenoceptor antagonist idazoxan. The alpha-2B preferential antagonists ARC-239, prazosin or chlorpromazine failed to block the modifications in both glycemic and insulin levels induced by alpha-2 adrenoceptor stimulation. The nonselective antagonists rauwolscine, yohimbine, WY 26703, phentolamine and corynanthine, as well as the receptor antagonists with alpha-2A selectivity like WB 4101, idazoxan and tolazoline, dose-dependently antagonized both the glycemic and the insulin responses to UK 14.304. A positive correlation was obtained between the potencies of these drugs in antagonizing the hyperglycemic response to UK 14.304 and their affinities for alpha-2A adrenergic receptors (r = 0.918, P less than .001) but no correlation was obtained with their affinities for alpha-2B adrenergic receptors (r = 0.048, P = N.S.)(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  F. Horio, S. Teradaira, T. Imamura, R. V. P Anunciado, M. Kobayashi, T. Namikawa, and I. Niki The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion Eur. J. Endocrinol., December 1, 2005; 153(6): 971 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cruciani-Guglielmacci, M. Vincent-Lamon, C. Rouch, M. Orosco, A. Ktorza, and C. Magnan Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E148 - E154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Michel, C. Plogmann, T. Philipp, and O.-E. Brodde Functional correlates of {alpha}2A-adrenoceptor gene polymorphism in the HANE study Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2657 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Schäfers, J. Nürnberger, B. Herrmann, R. R. Wenzel, T. Philipp, and M. C. Michel Adrenoceptors Mediating the Cardiovascular and Metabolic Effects of alpha -Methylnoradrenaline in Humans J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 918 - 925. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
